Intended for healthcare professionals

Letters Antibiotic prophylaxis

MRSA and Clostridium difficile are falling

BMJ 2010; 341 doi: (Published 27 July 2010) Cite this as: BMJ 2010;341:c4016
  1. Peter A Riley, consultant medical microbiologist1
  1. 1St George’s Healthcare NHS Trust, London SW17 0QT
  1. peter.riley{at}

    In their editorial on the use of co-trimoxazole as prophylaxis after percutaneous endoscopic gastrostomy, Kurien and Sanders state that the incidence of meticillin resistant Staphylococcus aureus (MRSA) and Clostridium difficile is increasing.1 In England this is …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription